NCT02974829|UnknownDMC
REALM China Extension Study
A 5-Year Follow-up Study of Subjects Who Completed REALM-China Study
Loading search results
A 5-Year Follow-up Study of Subjects Who Completed REALM-China Study
Sponsor study identifier
observational
4,000
1 country
50
Study Start
May 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
Not reported
Date not reportedThe purpose of this study is to conduct an investigator initiated observational study to continue to follow up the China subset of study participants for another 5 years after they complete participation in the REALM Study
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2016
Date type not reportedThis date has not been verified as actual or estimated.
November 23, 2016
Actual (reported)November 29, 2016
Actual (reported)January 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Treatment patterns in Study AI463520
year 5
Incidence rates of hepatitis B virus (HBV)-related clinical outcome events (COEs), such as non-hepatocellular carcinoma (HCC) HBV progression, HCC, and liver-related mortality, in Studies AI463080 and AI463520 combined, and in Study AI463520.
year 5
Antiviral efficacy endpoints on anti-HBV treatment in Studies AI463080 and AI463520.
year 5
Multivariate logistic regression models evaluating the relationship between pre-treatment biomarkers and antiviral efficacy endpoints on anti-HBV treatment in Study
year 5
Multivariate logistic regression models evaluating the relationship between baseline liver stiffness measurement (LSM) and HBV-related COEs outcomes in Study AI463520.
year 5
Continuing with marketed anti-HBV or off-treatment in real-life setting
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Chronic hepatitis B patients
First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
302 Military Hospital Of China
Beijing, Beijing Municipality, China
First Submitted
November 23, 2016
First Posted
November 29, 2016
Study Start
May 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2022
Estimated (date passed)Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy
Contact the study team to confirm eligibility.
Beijing Ditan Hospital
Beijing, Beijing Municipality, China
Beijing Friendship Hospital
Beijing, Beijing Municipality, China
People's Hospital of Beijing University
Beijing, Beijing Municipality, China
The Second Affiliated of ChongQing University of Medical Science
Chongqing, Chongqing Municipality, China
GuangZhou No. 8 People's Hospital
Guangzhou, Guangdong, China
Nanfang Hospital
Guangzhou, Guangdong, China
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Affiliated Hospital of Guiyang Medical College
Guiyang, Guizhou, China
People's hospital of Hainan Province
Haikou, Hainan, China
First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Medical Science Research Institute of Henan Province
Zhengzhou, Henan, China
People's Hospital of Henan Province
Zhengzhou, Henan, China
Tongji Hospital of Huazhong University of Science and Technology
Wuhan, Hubei, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Xiangya Hospital Central South University
Changsha, Hunan, China
No.81 Hospital of PLA
Nanjing, Jiangsu, China
The second hospital of nanjing
Nanjing, Jiangsu, China
Ningbo infectious disease hospital
Ningbo, Jiangsu, China
First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
People's hospital of Jiangsu Province
Suzhou, Jiangsu, China
First Hospital of Jilin Unniversity
Changchun, Jilin, China
No.6 People's hospital of Dalian
Dalian, Liaoning, China
ShengJing Hospital of China Medical University
Shengyang, Liaoning, China
No.6 People's hospital of Shenyang
Shenyang, Liaoning, China
Tangdu Hospital
Xi'an, Shaanxi, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Jinan infectious disease hospital
Jinan, Shandong, China
No.85 Hospital of PLA
Shanghai, Shanghai Municipality, China
Shanghai Ruijin Hospital
Shanghai, Shanghai Municipality, China
First Affiliated Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
West China Hospital of SiChuan University
Chengdu, Sichuan, China
The first affiliated hospital of kunming medical college
Kunming, Yunnan, China
First Affiliated Hospital of Zhejing University
Hangzhou, Zhejiang, China
Hangzhou No.6 people's hospital
Hangzhou, Zhejiang, China
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
First Affiliated Hospital of Beijing University
Beijing, China
You An Hospital
Beijing, China
Southwest Hospital Affiliated the Third Military Medical University
Chongqing, China
Changhai Hospital of the Second Military Medical University of Chinese PLA
Shanghai, China
Huashan hospital of fudan university
Shanghai, China
Renji Hospital of Shanghai Jiao Tong University
Shanghai, China
Shanghai jing 'an district central hospital
Shanghai, China
Shanghai No.5 People's Hospital
Shanghai, China
Shanghai Public Health Clinical Center
Shanghai, China
Zhongshan Hospital of Fudan University
Shanghai, China
No.3 people's hospital of shenzhen
Shenzhen, China
Tianjin infectious disease hospital
Tianjin, China
Tianjin third central hospital
Tianjin, China
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 29, 2016
Record last verified: 2016-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: